MedTrace Logo

The Multidisciplinary, Multimodality, But Minimalist Approach to Transfemoral Transcatheter Aortic Valve Replacement

NCT02287662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 411

Last updated 2018-07-06

No results posted yet for this study

Summary

The primary objective of this study is to determine the efficacy, safety and feasibility of next day discharge home in patients undergoing balloon-expandable transfemoral TAVR utilizing the Vancouver 3M Clinical Pathway in low, medium, and high volume North American centres.

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

Vancouver 3M Clinical Pathway

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • BC Centre for Improved Cardiovascular Health

    lead OTHER

Principal Investigators

  • David A Wood, MD · University of British Columbia

  • John A Webb, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-04-30
Completion
2018-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287662 on ClinicalTrials.gov